Wedmont Private Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.84M Buy
2,817
+1,202
+74% +$714K 0.04% 225
2026
Q2
$851K Sell
1,615
-184
-10% -$88.3K 0.02% 393
2026
Q1
$906K Sell
1,799
-30
-2% -$16.3K 0.03% 345
2025
Q4
$1.13M Buy
1,829
+145
+9% +$82K 0.04% 262
2025
Q3
$908K Buy
1,684
+619
+58% +$288K 0.03% 296
2025
Q2
$447K Sell
1,065
-1,053
-50% -$440K 0.02% 459
2025
Q1
$928K Sell
2,118
-65
-3% -$35.2K 0.05% 236
2024
Q4
$1.18M Sell
2,183
-155
-7% -$85.2K 0.06% 190
2024
Q3
$1.4M Buy
2,338
+291
+14% +$172K 0.08% 156
2024
Q2
$1.12M Buy
2,047
+407
+25% +$233K 0.07% 173
2024
Q1
$966K Buy
1,640
+277
+20% +$155K 0.07% 188
2023
Q4
$738K Sell
1,363
-320
-19% -$155K 0.06% 214
2023
Q3
$835K Buy
1,683
+93
+6% +$49.6K 0.08% 156
2023
Q2
$842K Sell
1,590
-643
-29% -$347K 0.09% 151
2023
Q1
$1.28M Sell
2,233
-188
-8% -$106K 0.17% 85
2022
Q4
$1.3M Buy
2,421
+228
+10% +$121K 0.19% 84
2022
Q3
$1.11M Buy
2,193
+406
+23% +$227K 0.22% 70
2022
Q2
$971K Buy
1,787
+216
+14% +$119K 0.21% 74
2022
Q1
$927K Buy
1,571
+395
+34% +$227K 0.21% 80
2021
Q4
$707K Buy
+1,176
New +$734K 0.22% 78

Other funds holding TMO

Wedmont Private Capital's TMO Position: Q3 2026 in Review

Wedmont Private Capital increased its Thermo Fisher Scientific (TMO) stake by 74% in Q3 2026, buying an estimated $714K and bringing the position to 2,817 shares worth $1.84M. The position accounts for 0.04% of the portfolio, ranked #225.

Wedmont Private Capital first reported a position in TMO in Q4 2021 and has held it in 20 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Wedmont Private Capital held 2,817 shares of Thermo Fisher Scientific worth $1.84M as of Q3 2026.
  • Wedmont Private Capital bought 1,202 Thermo Fisher Scientific shares in Q3 2026, an estimated $714K.
  • Thermo Fisher Scientific made up 0.04% of Wedmont Private Capital's portfolio in Q3 2026, its #225 holding.
  • Wedmont Private Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 20 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.